Skip to content

Spirulina Supplementation In Recovery From Damaging Exercise

Spirulina Supplementation In Recovery From Damaging Exercise

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06391957
Acronym
SPIRAL
Enrollment
30
Registered
2024-04-30
Start date
2024-01-04
Completion date
2024-09-30
Last updated
2024-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Damage Muscle

Keywords

spirulina, exercise recovery

Brief summary

Exercise can cause muscle damage, leading to a loss in muscle function, increased muscle soreness and inflammation. Evidence supports the use of nutritional strategies to help recovery. Spirulina is a type of algae. It is eaten as a food supplement as it is full of micronutrients, some which provide anti-inflammatory benefits. This work will assess the impact of taking spirulina supplements on recovery from hard exercise. Investigators will measure changes in muscle function, soreness and markers of inflammation.

Interventions

DIETARY_SUPPLEMENTPlacebo supplement

Participants consume a macronutrient matched placebo supplement 3 times daily for 5 consecutive days.

DIETARY_SUPPLEMENTSpirulina supplement

Participants consume a 3g spirulina supplement 3 times daily for 5 consecutive days.

PROCEDUREEccentric exercise

On the morning of Day 3 (where Day 1 is when participants start taking supplements), participants perform a single bout of eccentric exercise. The exercise protocol is performed on a single leg and involves 300 (10 sets of 30 repetitions separated by 120 seconds) voluntary maximal, isokinetic, eccentric contractions of the knee extensor. Exercise is performed using a Biodex System 3 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, USA), and contractions are performed at 60◦/s over an 80◦ range of motion.

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Are available and willing to attend St Luke's Campus, Exeter * Age 18 - 40 * BMI 18.5 - 30 kg/m2 * The participant exercises / plays sport for \> 2 h/week, but doesn't do structured resistance strength training * Self-reported as healthy (absence of injury or disease) * Have no known food allergy to algae * Are not taking any over the counter or prescribed medication that might interfere with study, e.g. anti-inflammatory medication * Non-smoker

Exclusion criteria

* Are unable to attend St Luke's Campus, Exeter * Are out-with age range 18 - 40 * BMI below 18.5 or above 30 kg/m2 * The participant does not exercise * The participant does regular structured resistance strength training * Known injury or disease that might influence study outcomes * Have a known food allergy to algae * Are taking over the counter or prescribed medication that might interfere with study, e.g. anti-inflammatory medication * Smoker

Design outcomes

Primary

MeasureTime frameDescription
Measure changes in the concentration of blood plasma inflammatory markers via immunoassay.Measurements take place across a 6 day experimental period.Blood plasma inflammatory markers will be measured before (baseline) and after eccentric exercise (at 3, 6, 24, 48 and 72 h post eccentric exercise) in both the spirulina and placebo group. Inflammatory markers that will be assessed include: interferon γ (IFN-γ), interleukin (IL) -1β, -4, -6, -10, tumour necrosis factor α (TNF-α) via immunoassay (pg/mL).

Secondary

MeasureTime frameDescription
Measure changes in muscle function of the quadriceps using knee extensor peak isometric torque on a Biodex System 3 isokinetic dynamometer.Measurements take place across a 6 day experimental period.Knee extensor peak isometric torque (three maximal isometric contractions at 75◦ of knee flexion) will be measured before (baseline) and after eccentric exercise (at 3, 6, 24, 48 and 72 h post eccentric exercise) in both the spirulina and placebo group to report recovery of peak isometric torque (N). Testing will be performed on a Biodex System 3 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, US).
Measure changes in muscle function of the quadriceps using knee extensor total isokinetic work on a Biodex System 3 isokinetic dynamometer.Measurements take place across a 6 day experimental period.Knee extensor total isokinetic work (area under the torque-time curve after 30 maximal, concentric, isokinetic knee extensor contractions performed at 75◦/s through an 80◦ range of motion) will be measured before (baseline) and after eccentric exercise (at 3, 6, 24, 48 and 72 h post eccentric exercise) in both the spirulina and placebo group to report recovery of total isokinetic work (N.s). Testing will be performed on a Biodex System 3 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, US).
Measure changes in perceived lower body muscle soreness via visual analogue scale questionnaire.Measurements take place across a 6 day experimental period.Perceived lower body muscle soreness will be measured before (baseline) and after eccentric exercise (at 3, 6, 24, 48 and 72 h post eccentric exercise) in both the spirulina and placebo group to report recovery of muscle. Participants will stand from a seated position and rate the corresponding sensation of lower body muscle soreness on a 100-mm visual analogue scale anchored by 'no pain' at 0 mm and 'worst possible pain' at 100 mm.

Countries

United Kingdom

Contacts

Primary ContactBenjamin Wall, Prof
b.t.wall@exeter.ac.uk+441392724774

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026